Jewish General Hospital ( Site 0032)

Montreal, Quebec H3T 1E2

0 studies enrolling now · 2 studies all time

What they study most

Castration Resistant Prostate Cancer, Hematological Malignancies, Microsatellite Stable Colorectal Cancer, Non-small Cell Lung Cancer, Solid Tumors

Studies at this site

• A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004) — Completed
• Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034) — Completed